Impairment of Immunological Functions in Genetically Epilepsy-Prone Rats

By De Sarro G.   Liberto M.C.   Berlinghieri M.C.   Foca A.   Aragona M.   Cavaliere R.   Gulletta E.  

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 643-646

Elsevier

Access to resources Recommend Favorite

Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats

By Graumlich J.F.   McLaughlin R.G.   Birkhahn D.   Shah N.   Burk A.   Jobe P.C.   Dailey J.W.  

European Journal of Pharmacology, Vol. 369, Iss. 3, 1999-03 ,pp. : 305-311

Elsevier

Access to resources Recommend Favorite

Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats

By Seo D.O.   Shin C.Y.   Ryu J.R.   Cheong J.H.   Choi C.-R.   Dailey J.W.   Reith M.E.A.   Jobe P.C.   Ko K.H.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats

By Tang E.   Yip P.K.   Chapman A.G.   Jane D.E.   Meldrum B.S.  

European Journal of Pharmacology, Vol. 327, Iss. 2, 1997-05 ,pp. : 109-115

Elsevier

Access to resources Recommend Favorite

5-HT 1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats

By Moser P.C.   Sanger D.J.  

European Journal of Pharmacology, Vol. 372, Iss. 2, 1999-05 ,pp. : 127-134

Elsevier

Access to resources Recommend Favorite